248 related articles for article (PubMed ID: 30442678)
1. Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.
Abu-Fanne R; Stepanova V; Litvinov RI; Abdeen S; Bdeir K; Higazi M; Maraga E; Nagaswami C; Mukhitov AR; Weisel JW; Cines DB; Higazi AA
Blood; 2019 Jan; 133(5):481-493. PubMed ID: 30442678
[TBL] [Abstract][Full Text] [Related]
2. Alpha-defensins: risk factor for thrombosis in COVID-19 infection.
Abdeen S; Bdeir K; Abu-Fanne R; Maraga E; Higazi M; Khurram N; Feldman M; Deshpande C; Litzky LA; Heyman SN; Montone KT; Cines DB; Higazi AA
Br J Haematol; 2021 Jul; 194(1):44-52. PubMed ID: 34053084
[TBL] [Abstract][Full Text] [Related]
3. α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol.
Abu-Fanne R; Maraga E; Abd-Elrahman I; Hankin A; Blum G; Abdeen S; Hijazi N; Cines DB; Higazi AA
J Biol Chem; 2016 Feb; 291(6):2777-86. PubMed ID: 26518877
[TBL] [Abstract][Full Text] [Related]
4. Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.
Cerrillo E; Moret I; Iborra M; Ramos D; Busó E; Tortosa L; Sáez-González E; Nos P; Beltrán B
Clin Exp Immunol; 2018 Apr; 192(1):120-128. PubMed ID: 29193023
[TBL] [Abstract][Full Text] [Related]
5. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.
Subramaniam S; Jurk K; Hobohm L; Jäckel S; Saffarzadeh M; Schwierczek K; Wenzel P; Langer F; Reinhardt C; Ruf W
Blood; 2017 Apr; 129(16):2291-2302. PubMed ID: 28223279
[TBL] [Abstract][Full Text] [Related]
6. Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow.
Yu X; Diamond SL
Thromb Haemost; 2019 Apr; 119(4):586-593. PubMed ID: 30722079
[TBL] [Abstract][Full Text] [Related]
7. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin.
Cines DB; Lebedeva T; Nagaswami C; Hayes V; Massefski W; Litvinov RI; Rauova L; Lowery TJ; Weisel JW
Blood; 2014 Mar; 123(10):1596-603. PubMed ID: 24335500
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones.
Longstaff C; Varjú I; Sótonyi P; Szabó L; Krumrey M; Hoell A; Bóta A; Varga Z; Komorowicz E; Kolev K
J Biol Chem; 2013 Mar; 288(10):6946-56. PubMed ID: 23293023
[TBL] [Abstract][Full Text] [Related]
9. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
10. Biomaterial Wettability Affects Fibrin Clot Structure and Fibrinolysis.
Ruhoff AM; Hong JK; Gao L; Singh J; Tran C; Mackie G; Waterhouse A
Adv Healthc Mater; 2021 Oct; 10(20):e2100988. PubMed ID: 34423587
[TBL] [Abstract][Full Text] [Related]
11. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
12. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
13. Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.
Abdeen S; Abu-Fanne R; Bdeir K; Maraga E; Higazi M; Cines DB; Heyman SN; Higazi AA
Br J Haematol; 2022 Feb; 196(4):923-927. PubMed ID: 34622440
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa.
Horn M; Bertling A; Brodde MF; Müller A; Roth J; Van Aken H; Jurk K; Heilmann C; Peters G; Kehrel BE
J Thromb Haemost; 2012 Apr; 10(4):647-61. PubMed ID: 22268819
[TBL] [Abstract][Full Text] [Related]
15. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a).
Scipione CA; McAiney JT; Simard DJ; Bazzi ZA; Gemin M; Romagnuolo R; Macrae FL; Ariëns RA; Hegele RA; Auld J; Gauld JW; Boffa MB; Koschinsky ML
J Thromb Haemost; 2017 Sep; 15(9):1834-1844. PubMed ID: 28632940
[TBL] [Abstract][Full Text] [Related]
17. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
[TBL] [Abstract][Full Text] [Related]
18. Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots.
Frick IM; Shannon O; Neumann A; Karlsson C; Wikström M; Björck L
J Biol Chem; 2018 Aug; 293(35):13578-13591. PubMed ID: 30002122
[TBL] [Abstract][Full Text] [Related]
19. Opposing effects of HNP1 (α-defensin-1) on plasma cholesterol and atherogenesis.
Higazi M; Abdeen S; Abu-Fanne R; Heyman SN; Masarwy A; Bdeir K; Maraga E; Cines DB; Higazi AA
PLoS One; 2020; 15(4):e0231582. PubMed ID: 32302327
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
Sauls DL; Wolberg AS; Hoffman M
J Thromb Haemost; 2003 Feb; 1(2):300-6. PubMed ID: 12871504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
